Xueqing Lu, PhD
Xueqing Lu joined Antigen Express in October of 2000.
research engages in the design and cloning of expressible antisense gene constructs into DNA vaccine vectors evaluated for Ii-suppression in situ.
also explores the induction of MHC class II(+)/Ii(-) phenotype via RNAi delivery into tumor cell lines.
Xueqing received his PhD in Chemistry from Shanghai University of Chinese Traditional Medicine and Pharmacology in 1999.